In Case You Missed It
5 Things You Must Know Before the Market Opens
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Mylan Inc.
The company's shares were falling again on Wednesday, this time on the news that its initial application for an anti-asthma generic had been rejected by the FDA.
The S&P 500 inches higher in mixed trading Wednesday as a rally in crude helps the energy sector.
The company could be gearing up for multiple challenges on the D.C. front, analysts say.
The company hired Paul Bisaro, former chairman at Allergan, to become CEO as Morgan Stanley helps explore alternatives, including a sale.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.